Cardiovascular Drugs in Pregnancy

被引：25

作者：

Frishman, William H. ^{[1
]}

Elkayam, Uri ^{[2
]}

Aronow, Wilbert S. ^{[1
]}

机构：

[1] New York Med Coll, Westchester Med Ctr, Dept Med, Div Cardiol, Valhalla, NY 10595 USA

[2] USC Sch Med, Dept Med, Los Angeles, CA 90033 USA

来源：

CARDIOLOGY CLINICS | 2012年 / 30卷 / 03期

关键词：

Pregnancy; Gestation; Teratogenic fetal risk; Pharmacotoxicity; Adverse reactions; FETAL SUPRAVENTRICULAR TACHYCARDIA; CONVERTING-ENZYME-INHIBITOR; MOLECULAR-WEIGHT HEPARIN; SODIUM-NITROPRUSSIDE; AMIODARONE TREATMENT; PLASMINOGEN-ACTIVATOR; SUBCUTANEOUS HEPARIN; HEMODYNAMIC-CHANGES; PULMONARY-EMBOLISM; ATRIAL-FLUTTER;

D O I：

10.1016/j.ccl.2012.04.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular drugs are used in pregnancy to treat maternal and fetal conditions. Mothers may also require drug therapy postpartum. Most cardiovascular drugs taken by pregnant women can cross the placenta and therefore expose the developing embryo and fetus to their pharmacologic and teratogenic effects. These effects are influenced by the intrinsic pharmacokinetic properties of a given drug and by the complex physiologic changes occurring during pregnancy. Many drugs are also transferred into human milk with potential adverse effects on the nursing infant. This article summarizes some of the literature concerning the risks and benefits of using cardiovascular drugs during pregnancy.

引用

页码：463 / +

页数：30

共 166 条

[41]

FORESTIER F, 1987, THROMB HAEMOSTASIS, V57, P234

[42]

Frishman MD, 2011, CARDIOVASCULAR PHARM, P57

[43]

Frishman W.H., 2011, CARDIOVASCULAR PHARM, P323

[44]

Frishman WH, 2011, CARDIOVASCULAR PHARM, P99

[45]

Frishman WSD, 2011, CARDIOVASCULAR PHARM

[46]

Gewitz M, 2011, CARDIOVASCULAR PHARM, P519

[47] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy [J].

Gifford, RW ;

August, PA ;

Cunningham, G ;

Green, LA ;

Lindheimer, MD ;

McNellis, D ;

Roberts, JM ;

Sibai, BM ;

Taler, SJ .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (01) :S1-S22

[48]

GINSBERG JS, 1989, THROMB HAEMOSTASIS, V61, P197

[49] Use of antithrombotic agents during pregnancy [J].

Ginsberg, JS ;

Greer, I ;

Hirsh, J .

CHEST, 2001, 119 (01) :122S-131S

[50] PROPRANOLOL ADMINISTRATION DURING PREGNANCY - EFFECTS ON FETUS [J].

GLADSTONE, GR ;

HORDOF, A ;

GERSONY, WM .

JOURNAL OF PEDIATRICS, 1975, 86 (06) :962-964

← 1 2 3 4 5 6 7 8 9 10 →